T1	PROC 44 86	Estudio aleatorizado, abierto y controlado
T2	DISO 186 193	COVID19
#1	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
T3	CHEM 116 126	Colchicina
#2	AnnotatorNotes T3	C0009262; colchicine; Organic Chemical · Pharmacologic Substance
T4	DISO 144 163	enfermedad COVID-19
#3	AnnotatorNotes T4	C5203670; COVID19 (disease); Disease or Syndrome
T5	DISO 223 258	Infección confirmada por SARS-CoV-2
T6	PROC 268 274	RT-PCR
#4	AnnotatorNotes T6	C0599161; Reverse Transcriptase Polymerase Chain Reaction; Molecular Biology Research Technique
T7	PROC 279 299	Ingreso hospitalario
#5	AnnotatorNotes T7	C0184666; Hospital admission; Health Care Activity
T8	DISO 328 346	afectación clínica
T9	PROC 527 556	soporte ventilatorio invasivo
T10	DISO 623 657	Enfermedad inflamatoria intestinal
#6	AnnotatorNotes T10	C0021390; Inflammatory Bowel Diseases; Disease or Syndrome
T11	DISO 659 678	enfermedad de Crohn
#7	AnnotatorNotes T11	C0010346; Crohn Disease; Disease or Syndrome
T12	DISO 681 697	colitis ulcerosa
#8	AnnotatorNotes T12	C0009324; Ulcerative Colitis; Disease or Syndrome
T13	DISO 700 715	diarrea crónica
#9	AnnotatorNotes T13	C0401151; Chronic diarrhea; Disease or Syndrome
T14	DISO 718 730	malabsorción
#10	AnnotatorNotes T14	C0024523; Malabsorption Syndrome; Disease or Syndrome | C3714745; Malabsorption; Finding
T15	DISO 735 759	Enfermedad neuromuscular
#11	AnnotatorNotes T15	C0027868; Neuromuscular Diseases; Disease or Syndrome
T16	DISO 770 780	Enfermedad
#12	AnnotatorNotes T16	C0012634; Disease; Disease or Syndrome
T17	DISO 840 859	Insuficiencia renal
#13	AnnotatorNotes T17	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T18	PROC 867 894	tasa de filtrado glomerular
#14	AnnotatorNotes T18	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T19	DISO 934 942	cirrosis
#15	AnnotatorNotes T19	C1623038; Cirrhosis; Disease or Syndrome
T20	DISO 944 968	hepatitis crónica activa
#16	AnnotatorNotes T20	C0520463; Chronic active hepatitis; Disease or Syndrome
T21	DISO 971 990	enfermedad hepática
#17	AnnotatorNotes T21	C0023895; Liver diseases; Disease or Syndrome
T22	PROC 1011 1022	valores GOT
T23	PROC 1031 1034	GPT
#18	AnnotatorNotes T23	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T24	CHEM 1124 1134	colchicina
#19	AnnotatorNotes T24	C0009262; colchicine; Organic Chemical · Pharmacologic Substance
T25	PROC 1175 1189	prescripciones
#20	AnnotatorNotes T25	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T26	DISO 1204 1236	fiebre familiar del mediterráneo
#21	AnnotatorNotes T26	C0031069; Familial Mediterranean Fever; Disease or Syndrome
T27	DISO 1239 1243	gota
#22	AnnotatorNotes T27	C0018099; Gout; Disease or Syndrome
T28	PROC 1310 1318	tratados
#23	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	CHEM 1323 1333	colchicina
#24	AnnotatorNotes T29	C0009262; colchicine; Organic Chemical · Pharmacologic Substance
T30	PROC 1342 1363	dejado el tratamiento
#25	AnnotatorNotes T30	C0850893; stop medication; Therapeutic or Preventive Procedure
T31	PROC 1376 1390	aleatorización
#26	AnnotatorNotes T31	C0034656; Randomization; Research Activity
T32	DISO 1425 1445	reacciones alérgicas
#27	AnnotatorNotes T32	C1527304; Allergic Reaction; Pathologic Function
T33	CHEM 1480 1490	colchicina
#28	AnnotatorNotes T33	C0009262; colchicine; Organic Chemical · Pharmacologic Substance
T34	PROC 1496 1507	Tratamiento
#29	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	CHEM 1530 1541	corticoides
#30	AnnotatorNotes T35	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T36	CHEM 1512 1528	inmunosopresores
T37	PROC 1823 1866	analítica de gonadotropina coriónica humana
T38	CHEM 1836 1866	gonadotropina coriónica humana
#31	AnnotatorNotes T38	C1141639; human chorionic gonadotropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T39	PROC 1868 1871	hCG
T40	PROC 1945 1973	esterilizada quirúrgicamente
T41	PROC 2047 2068	método anticonceptivo
#32	AnnotatorNotes T41	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T42	PROC 2118 2132	anticoncepción
#33	AnnotatorNotes T42	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T43	PROC 2148 2162	método barrera
#34	AnnotatorNotes T43	C0004764; Contraception, Barrier; Therapeutic or Preventive Procedure
T44	CHEM 2202 2214	espermicidas
#35	AnnotatorNotes T44	C0037862; Spermatocidal Agents; Pharmacologic Substance
T45	CHEM 2235 2256	geles anticonceptivos
T46	CHEM 2397 2422	fármacos en investigación
#36	AnnotatorNotes T46	C0013230; Investigational New Drugs; Pharmacologic Substance
T47	PROC 447 483	consentimiento informado por escrito
#37	AnnotatorNotes T47	C0811741; Obtain informed written consent; Health Care Activity
T48	ANAT 647 657	intestinal
#38	AnnotatorNotes T48	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T49	ANAT 746 759	neuromuscular
#39	AnnotatorNotes T49	C0597054; neuromuscular system; Body System
T50	ANAT 854 859	renal
#40	AnnotatorNotes T50	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T51	ANAT 982 990	hepática
#41	AnnotatorNotes T51	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T52	PROC 1024 1027	AST
#42	AnnotatorNotes T52	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T53	PROC 1036 1039	ALT
#43	AnnotatorNotes T53	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T54	DISO 1448 1460	sensibilidad
T55	CHEM 1543 1576	antagonistas de la interleukina-1
T56	PHYS 1906 1920	posmenopáusica
#44	AnnotatorNotes T56	C0206159; Postmenopause; Organism Function
T57	ANAT 1850 1859	coriónica
#45	AnnotatorNotes T57	C0008503; Chorion; Embryonic Structure
T59	Date 12 16	2020
T60	LIVB 130 139	pacientes
#46	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 248 258	SARS-CoV-2
#47	AnnotatorNotes T61	C5203676; SARS-CoV-2; Virus
T62	Duration 303 323	las 48 horas previas
T63	Age 410 426	mayor de 18 años
T64	Duration 708 715	crónica
#48	AnnotatorNotes T64	C0205191; chronic; Temporal Concept
T65	Duration 820 834	menor de 1 año
T66	PHYS 875 894	filtrado glomerular
#49	AnnotatorNotes T66	C0232809; Glomerular filtration; Organ or Tissue Function; Laboratory Procedure
T67	Duration 954 961	crónica
#50	AnnotatorNotes T67	C0205191; chronic; Temporal Concept
T68	LIVB 1090 1098	Paciente
#51	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Duration 1190 1198	crónicas
#52	AnnotatorNotes T69	C0205191; chronic; Temporal Concept
T71	LIVB 1285 1294	pacientes
#53	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T72	LIVB 1396 1404	Paciente
#54	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T74	Duration 1580 1591	los 6 meses
T75	LIVB 1620 1665	Mujeres embarazadas o en periodo de lactancia
#55	AnnotatorNotes T75	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T76	PHYS 1673 1681	embarazo
#56	AnnotatorNotes T76	C0032961; Pregnancy; Organism Function
T77	LIVB 1714 1719	mujer
#57	AnnotatorNotes T77	C0043210; Woman; Population Group
T78	PHYS 1734 1744	concepción
#58	AnnotatorNotes T78	C0009637; Conception; Organism Function | C0015914; Fertilization; Organism Function
T79	PHYS 1769 1778	gestación
#59	AnnotatorNotes T79	C0032961; Pregnancy; Organism Function
T80	LIVB 1878 1902	Paciente femenino fértil
#60	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group + C4324275; Woman of childbearing potential; Population Group
T83	Duration 1924 1938	menos de 1 año
T84	Neg_cue 1942 1944	no
T85	LIVB 1992 2014	mujeres en edad fértil
#61	AnnotatorNotes T85	C4324275; Woman of childbearing potential; Population Group
T86	Age 2003 2014	edad fértil
T88	DEVI 2164 2200	preservativos masculinos o femeninos
#62	AnnotatorNotes T88	C0009653; Condoms, Male; Medical Device + C0221829; Female Condoms; Medical Device
T90	Form 2235 2240	geles
T91	DEVI 2270 2294	dispositivo intrauterino
#63	AnnotatorNotes T91	C0021900; Intrauterine Devices; Medical Device
T92	Duration 2334 2341	30 días
T93	Duration 2464 2475	los 30 días
T96	DEVI 2216 2224	esponjas
#64	AnnotatorNotes T96	C0441126; Sponges; Medical Device
T97	DEVI 2258 2268	diafragmas
#65	AnnotatorNotes T97	C0042241; Vaginal contraceptive diaphragm (device); Medical Device
T70	PHYS 1628 1639	embarazadas
#66	AnnotatorNotes T70	C0032961; Pregnancy; Organism Function
T73	PHYS 1656 1665	lactancia
#67	AnnotatorNotes T73	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T81	Form 2226 2233	espumas
T58	ANAT 884 894	glomerular
#68	AnnotatorNotes T58	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Status T19 History_of
A2	Status T20 History_of
A3	Status T21 History_of
A4	Status T32 History_of
A5	Status T54 History_of
A7	Assertion T40 Negated
A8	Population_data T85 Age
A9	Status T15 History_of
A10	Status T28 History_of
A11	Status T29 History_of
#69	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
#70	AnnotatorNotes T22	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
#71	AnnotatorNotes T54	C0020517; Hypersensitivity; Pathologic Function 
#72	AnnotatorNotes T36	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
#73	AnnotatorNotes T81	C0991510; Foam drug form; Biomedical or Dental Material
#74	AnnotatorNotes T90	C0017243; Gel; Biomedical or Dental Material 
T82	Neg_cue 1246 1248	No
T87	CONC 1262 1279	periodo de lavado
A12	Assertion T87 Negated
#75	AnnotatorNotes T87	C1710661; Washout Period; Temporal Concept
R1	Negation Arg1:T82 Arg2:T87	
R2	Negation Arg1:T84 Arg2:T40	
T89	Observation 103 112	beneficio
#76	AnnotatorNotes T89	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R3	Causes Arg1:T3 Arg2:T89	
R4	Experiences Arg1:T60 Arg2:T3	
R5	Experiences Arg1:T60 Arg2:T4	
R6	Causes Arg1:T61 Arg2:T5	
R9	Overlap Arg1:T7 Arg2:T62	
T94	CONC 376 400	escala clínica de la OMS
T95	Quantifier_or_Qualifier 354 369	grupos 3, 4 o 5
R10	Has_Quantifier_or_Qualifier Arg1:T94 Arg2:T95	
#77	AnnotatorNotes T9	C1868981; Invasive mechanical ventilation; Therapeutic or Preventive Procedure
T98	Observation 599 619	mal pronóstico vital
#78	AnnotatorNotes T98	C0278252; Prognosis bad; Finding
T99	PROC 560 594	Limitación de esfuerzo terapéutico
R11	Overlap Arg1:T99 Arg2:T98	
R12	Location_of Arg1:T48 Arg2:T10	
R13	Location_of Arg1:T48 Arg2:T11	
R14	Location_of Arg1:T48 Arg2:T12	
R15	Has_Duration_or_Interval Arg1:T13 Arg2:T64	
R16	Location_of Arg1:T48 Arg2:T14	
R17	Location_of Arg1:T49 Arg2:T15	
T100	CONC 794 819	pronóstico vital estimado
#79	AnnotatorNotes T100	C0023671; Life Expectancy; Group Attribute
R18	Has_Duration_or_Interval Arg1:T100 Arg2:T65	
R19	Location_of Arg1:T50 Arg2:T17	
R21	Location_of Arg1:T58 Arg2:T66	
R22	Location_of Arg1:T58 Arg2:T18	
T101	Result_or_Value 895 913	<30 mL/m in/1.73m2
R23	Has_Result_or_Value Arg1:T18 Arg2:T101	
T102	Quantifier_or_Qualifier 860 865	grave
#80	AnnotatorNotes T102	C1547227; Severe - Severity of Illness Code; Intellectual Product
R25	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T102	
R26	Has_Duration_or_Interval Arg1:T20 Arg2:T67	
R27	Location_of Arg1:T51 Arg2:T21	
T103	Quantifier_or_Qualifier 991 997	severa
#81	AnnotatorNotes T103	C1547227; Severe - Severity of Illness Code; Intellectual Product
R28	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T103	
T104	Result_or_Value 1045 1086	superen 3 x límite superior de normalidad
R33	Has_Result_or_Value Arg1:T22 Arg2:T104	
R34	Has_Result_or_Value Arg1:T52 Arg2:T104	
R35	Has_Result_or_Value Arg1:T23 Arg2:T104	
R36	Has_Result_or_Value Arg1:T53 Arg2:T104	
R37	Experiences Arg1:T68 Arg2:T24	
R38	Before Arg1:T25 Arg2:T24	
R39	Has_Duration_or_Interval Arg1:T24 Arg2:T69	
R40	Experiences Arg1:T68 Arg2:T26	
R41	Experiences Arg1:T68 Arg2:T27	
R42	Experiences Arg1:T71 Arg2:T28	
R43	Used_for Arg1:T29 Arg2:T28	
R44	Before Arg1:T28 Arg2:T87	
R45	Before Arg1:T28 Arg2:T30	
R46	Before Arg1:T30 Arg2:T31	
R47	Experiences Arg1:T71 Arg2:T30	
R48	Experiences Arg1:T72 Arg2:T32	
R49	Experiences Arg1:T72 Arg2:T54	
R50	Causes Arg1:T33 Arg2:T54	
R51	Causes Arg1:T33 Arg2:T32	
T105	Quantifier_or_Qualifier 1461 1474	significativa
#82	AnnotatorNotes T105	C1546944; Event Seriousness - Significant; Qualitative Concept
R52	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T105	
A6	Status T105 History_of
R54	Used_for Arg1:T36 Arg2:T34	
R55	Used_for Arg1:T35 Arg2:T34	
R56	Used_for Arg1:T55 Arg2:T34	
#83	AnnotatorNotes T55	C1704264; Interleukin 1 Receptor Antagonist Protein; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?) | C3536785; Interleukin-1 Receptor Antagonist [EPC]; Pharmacologic Substance (?)
R57	Overlap Arg1:T36 Arg2:T74	
R58	Overlap Arg1:T35 Arg2:T74	
R59	Overlap Arg1:T55 Arg2:T74	
T106	CONC 1605 1614	inclusión
#84	AnnotatorNotes T106	C1512693; Inclusion; Qualitative Concept
R60	Before Arg1:T34 Arg2:T106	
R61	Experiences Arg1:T75 Arg2:T70	
R62	Experiences Arg1:T75 Arg2:T73	
R63	Experiences Arg1:T75 Arg2:T76	
R64	After Arg1:T76 Arg2:T78	
R65	Before Arg1:T78 Arg2:T79	
R66	Experiences Arg1:T77 Arg2:T76	
R67	Experiences Arg1:T77 Arg2:T78	
R68	Experiences Arg1:T77 Arg2:T79	
R69	Experiences Arg1:T77 Arg2:T70	
R70	After Arg1:T70 Arg2:T78	
T107	Result_or_Value 1798 1816	resultado positivo
#85	AnnotatorNotes T107	C1446409; Positive; Finding
R71	Has_Result_or_Value Arg1:T37 Arg2:T107	
R72	Has_Result_or_Value Arg1:T39 Arg2:T107	
#86	AnnotatorNotes T37	C0428402; Human chorionic gonadotropin measurement; Laboratory Procedure
#87	AnnotatorNotes T39	C0428402; Human chorionic gonadotropin measurement; Laboratory Procedure
R79	Has_Duration_or_Interval Arg1:T56 Arg2:T83	
R80	Overlap Arg1:T56 Arg2:T40	
R81	Has_Age Arg1:T85 Arg2:T86	
T108	Quantifier_or_Qualifier 2035 2046	al menos un
R82	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T108	
R83	Experiences Arg1:T85 Arg2:T41	
T109	Quantifier_or_Qualifier 2087 2090	dos
R84	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T109	
R85	Used_for Arg1:T88 Arg2:T43	
R86	Used_for Arg1:T44 Arg2:T43	
R87	Used_for Arg1:T96 Arg2:T43	
R88	Has_Drug_Form Arg1:T45 Arg2:T90	
R89	Used_for Arg1:T45 Arg2:T43	
#88	AnnotatorNotes T45	C5570694; Contraceptive gel; Pharmacologic Substance
R90	Used_for Arg1:T81 Arg2:T43	
R91	Experiences Arg1:T85 Arg2:T42	
R92	Experiences Arg1:T85 Arg2:T43	
T110	PROC 2318 2325	estudio
#89	AnnotatorNotes T110	C0008976; Clinical Trials; Research Activity
R93	Overlap Arg1:T41 Arg2:T110	
R94	Overlap Arg1:T42 Arg2:T110	
R95	Overlap Arg1:T43 Arg2:T110	
R96	Has_Duration_or_Interval Arg1:T41 Arg2:T92	
R97	Has_Duration_or_Interval Arg1:T42 Arg2:T92	
R98	Has_Duration_or_Interval Arg1:T88 Arg2:T92	
R99	Has_Duration_or_Interval Arg1:T43 Arg2:T92	
R100	Has_Duration_or_Interval Arg1:T44 Arg2:T92	
R101	Has_Duration_or_Interval Arg1:T96 Arg2:T92	
R102	Has_Duration_or_Interval Arg1:T45 Arg2:T92	
R103	Used_for Arg1:T97 Arg2:T43	
R104	Has_Duration_or_Interval Arg1:T97 Arg2:T92	
R105	Used_for Arg1:T91 Arg2:T43	
R106	Has_Duration_or_Interval Arg1:T91 Arg2:T92	
R107	Has_Duration_or_Interval Arg1:T81 Arg2:T92	
R108	Overlap Arg1:T88 Arg2:T110	
R109	Overlap Arg1:T44 Arg2:T110	
R110	Overlap Arg1:T96 Arg2:T110	
R111	Overlap Arg1:T45 Arg2:T110	
R112	Overlap Arg1:T97 Arg2:T110	
R113	Overlap Arg1:T91 Arg2:T110	
R114	Overlap Arg1:T81 Arg2:T110	
T111	CONC 2356 2368	finalización
#90	AnnotatorNotes T111	C4283764; Trial participation end date; Temporal Concept
R115	After Arg1:T81 Arg2:T111	
R116	After Arg1:T45 Arg2:T111	
R117	After Arg1:T97 Arg2:T111	
R118	After Arg1:T91 Arg2:T111	
R119	After Arg1:T88 Arg2:T111	
R120	After Arg1:T44 Arg2:T111	
R121	After Arg1:T96 Arg2:T111	
R122	After Arg1:T43 Arg2:T111	
R123	After Arg1:T42 Arg2:T111	
R124	After Arg1:T41 Arg2:T111	
T112	Quantifier_or_Qualifier 2391 2396	otros
#91	AnnotatorNotes T112	C0205394; Other; Qualitative Concept
R125	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T112	
T113	CONC 2443 2452	inclusión
#92	AnnotatorNotes T113	C1512693; Inclusion; Qualitative Concept
R126	Overlap Arg1:T46 Arg2:T113	
T114	CONC 2492 2501	inclusión
#93	AnnotatorNotes T114	C1512693; Inclusion; Qualitative Concept
R127	Has_Duration_or_Interval Arg1:T46 Arg2:T93	
R128	Before Arg1:T46 Arg2:T114	
R129	Before Arg1:T8 Arg2:T7	
R53	Experiences Arg1:T77 Arg2:T37	
R73	Experiences Arg1:T77 Arg2:T39	
R74	Experiences Arg1:T60 Arg2:T89	
#94	AnnotatorNotes T109	C0205448; Two; Quantitative Concept
#95	AnnotatorNotes T94	C5706704; COVID-19 Disease WHO Severity Scale; Intellectual Product (?)
#96	AnnotatorNotes T99	C0871549; Withholding Treatment; Health Care Activity
A13	Experiencer T71 Patient
A14	Experiencer T68 Patient
A15	Experiencer T72 Patient
A16	Experiencer T60 Patient
A17	Experiencer T75 Patient
A18	Experiencer T77 Patient
A19	Experiencer T80 Patient
A20	Experiencer T85 Patient
